Crossmark

Biochemical validation for the therapeutic use of Plumeria rubra in coagulation disorders: a study combining in silico, in vitro, and in vivo approaches

Crossref DOI link: https://doi.org/10.1007/s00709-025-02055-z

Published Online: 2025-04-21

Published Print: 2025-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Khan, Imran Ahmad https://orcid.org/0000-0002-8761-8879
Anwar, Muhammad

Arshad, Sarmad Frogh

Hussain, Athar

Usman, Muhammad

Ansari, Mohammed Nadeem

Arshad, Hasan Junaid

Rukh, Asma Shah

Ain, Qurat Ul

Khan, Maliha Khalid
Funding

Funding for this research was provided by:

Hainan University
License Information

Text and Data Mining valid from 2025-04-21

Version of Record valid from 2025-04-21
More Information

Article History

Received: 20 April 2024

Accepted: 18 March 2025

First Online: 21 April 2025

Declarations

: Animal Ethical Committee for the Department of Life Sciences (MIMAS/22/imran/IRB/2) approved and all the tests were conducted per NIH criteria.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below